Compared to Estimates, Corteva, Inc. (CTVA) Q4 Earnings: A Look at Key Metrics
For the quarter ended December 2025, Corteva, Inc. (CTVA) reported revenue of $3.91 billion, down 1.7% over the same period last year. EPS came in at $0.22, compared to $0.32 in the year-ago quarter.
The reported revenue represents a surprise of -7.49% over the Zacks Consensus Estimate of $4.23 billion. With the consensus EPS estimate being $0.21, the EPS surprise was +3.14%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Corteva, Inc. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:- Revenue- Crop Protection: $2.17 billion compared to the $2.41 billion average estimate based on four analysts. The reported number represents a change of -1.5% year over year.
- Revenue- Seed: $1.74 billion versus the four-analyst average estimate of $1.82 billion. The reported number represents a year-over-year change of -2%.
- Revenue- Seed- Other oilseeds: $94 million versus $89.86 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +8.1% change.
- Revenue- Crop Protection- Biologicals: $191 million versus the two-analyst average estimate of $186.79 million.
- Revenue- Crop Protection- Herbicides: $1.06 billion versus $1.14 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +3% change.
- Revenue- Crop Protection- Insecticides: $488 million compared to the $557.11 million average estimate based on two analysts. The reported number represents a change of -0.4% year over year.
- Revenue- Crop Protection- Fungicides: $272 million versus the two-analyst average estimate of $357.43 million. The reported number represents a year-over-year change of -15%.
- Revenue- Crop Protection- Other: $160 million versus the two-analyst average estimate of $213.87 million. The reported number represents a year-over-year change of -18.4%.
- Revenue- Seed- Soybean: $164 million compared to the $155.13 million average estimate based on two analysts. The reported number represents a change of +6.5% year over year.
- Revenue- Seed- Corn: $1.39 billion versus $1.41 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -1.8% change.
- Revenue- Seed- Other: $93 million compared to the $138.89 million average estimate based on two analysts. The reported number represents a change of -22.5% year over year.
- Operating EBITDA- Seed: $124 million compared to the $103.5 million average estimate based on three analysts.
View all Key Company Metrics for Corteva, Inc. here>>>
Shares of Corteva, Inc. have returned +7.9% over the past month versus the Zacks S&P 500 composite's +1.8% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.Radical New Technology Could Hand Investors Huge Gains
Quantum Computing is the next technological revolution, and it could be even more advanced than AI.
While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.
Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power.
Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.
See Top Quantum Stocks Now >>Corteva, Inc. (CTVA) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
